Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedIntroduces a Locations section showing Utah as a site and updates the page revision to v3.3.3. Removes the previous Utah Locations entry and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPubMed-related publication notes were updated: an addition states that publications are automatically filled from PubMed and may not all relate to the study, and the revision version updated to v3.3.2; the previous wording indicating auto-generation by ClinicalTrials.gov and revision v3.2.0 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe funding notice banner about potential delays due to government funding has been removed. Other study details and navigation remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant updates were detected; the study details, eligibility criteria, and listed outcomes remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 revision; removed the old v3.1.0 revision.SummaryDifference3%

- Check99 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.